Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036408906> ?p ?o ?g. }
- W2036408906 endingPage "201" @default.
- W2036408906 startingPage "193" @default.
- W2036408906 abstract "Growth modulation index (GMI), the ratio of two times to progression measured in patients receiving two successive treatments (GMI = TTP2/TTP1), has been proposed as a criterion of phase II clinical trials. Nevertheless, its use has been limited until now.We carried out a retrospective multicentre study in soft tissue sarcoma patients receiving a second-line treatment after doxorubicin-based regimens to evaluate the link between overall survival and GMI. Second-line treatments were classified as ‘active’ according to the EORTC-STBSG criteria (3-month progression-free rate >40% or 6-month PFR >14%). Comparisons used chi-squared and log-rank tests.The population consisted in 106 men and 121 women, 110 patients (48%) received ‘active drugs’. Median OS from the second-line start was 317 days. Sixty-nine patients experienced GMI >1.33 (30.4%). Treatments with ‘active drug’ were not associated with OS improvement: 490 versus 407 days (P = 0.524). Median OS was highly correlated with GMI: 324, 302 and 710 days with GMI <1, GMI = [1.00–1.33], and GMI >1.33, respectively (P < 0.0001). In logistic regression analysis, the sole predictive factor was the number of doxorubicin-based chemotherapy cycles.GMI seems to be an interesting end point that provides additional information compared with classical criteria. GMI >1.33 is associated with significant OS improvement." @default.
- W2036408906 created "2016-06-24" @default.
- W2036408906 creator A5004384935 @default.
- W2036408906 creator A5011819733 @default.
- W2036408906 creator A5016593577 @default.
- W2036408906 creator A5024897875 @default.
- W2036408906 creator A5034364316 @default.
- W2036408906 creator A5057360920 @default.
- W2036408906 creator A5070725728 @default.
- W2036408906 creator A5071541231 @default.
- W2036408906 date "1995-10-01" @default.
- W2036408906 modified "2023-09-25" @default.
- W2036408906 title "The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view" @default.
- W2036408906 cites W1876135160 @default.
- W2036408906 cites W1892579032 @default.
- W2036408906 cites W1901845528 @default.
- W2036408906 cites W1928072155 @default.
- W2036408906 cites W1943427806 @default.
- W2036408906 cites W1969858593 @default.
- W2036408906 cites W1975650762 @default.
- W2036408906 cites W1986666007 @default.
- W2036408906 cites W1991164747 @default.
- W2036408906 cites W1992258198 @default.
- W2036408906 cites W2009208717 @default.
- W2036408906 cites W2013313438 @default.
- W2036408906 cites W2021484735 @default.
- W2036408906 cites W2024841231 @default.
- W2036408906 cites W2030251285 @default.
- W2036408906 cites W2030567249 @default.
- W2036408906 cites W2034328882 @default.
- W2036408906 cites W2038448746 @default.
- W2036408906 cites W2057503794 @default.
- W2036408906 cites W2064722407 @default.
- W2036408906 cites W2072404545 @default.
- W2036408906 cites W2082065626 @default.
- W2036408906 cites W2083438316 @default.
- W2036408906 cites W2100130459 @default.
- W2036408906 cites W2125819884 @default.
- W2036408906 cites W2126540415 @default.
- W2036408906 cites W2150912507 @default.
- W2036408906 cites W2157504612 @default.
- W2036408906 cites W2230867484 @default.
- W2036408906 cites W2247969479 @default.
- W2036408906 cites W225519924 @default.
- W2036408906 cites W2257345960 @default.
- W2036408906 cites W2265301974 @default.
- W2036408906 cites W2266212450 @default.
- W2036408906 cites W2322407117 @default.
- W2036408906 cites W2324576435 @default.
- W2036408906 cites W2409107116 @default.
- W2036408906 doi "https://doi.org/10.1016/1040-8428(94)00146-k" @default.
- W2036408906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8748009" @default.
- W2036408906 hasPublicationYear "1995" @default.
- W2036408906 type Work @default.
- W2036408906 sameAs 2036408906 @default.
- W2036408906 citedByCount "48" @default.
- W2036408906 countsByYear W20364089062012 @default.
- W2036408906 countsByYear W20364089062013 @default.
- W2036408906 crossrefType "journal-article" @default.
- W2036408906 hasAuthorship W2036408906A5004384935 @default.
- W2036408906 hasAuthorship W2036408906A5011819733 @default.
- W2036408906 hasAuthorship W2036408906A5016593577 @default.
- W2036408906 hasAuthorship W2036408906A5024897875 @default.
- W2036408906 hasAuthorship W2036408906A5034364316 @default.
- W2036408906 hasAuthorship W2036408906A5057360920 @default.
- W2036408906 hasAuthorship W2036408906A5070725728 @default.
- W2036408906 hasAuthorship W2036408906A5071541231 @default.
- W2036408906 hasConcept C126322002 @default.
- W2036408906 hasConcept C136948725 @default.
- W2036408906 hasConcept C141071460 @default.
- W2036408906 hasConcept C141341695 @default.
- W2036408906 hasConcept C142724271 @default.
- W2036408906 hasConcept C143998085 @default.
- W2036408906 hasConcept C151956035 @default.
- W2036408906 hasConcept C167135981 @default.
- W2036408906 hasConcept C2776694085 @default.
- W2036408906 hasConcept C2778256501 @default.
- W2036408906 hasConcept C2778629024 @default.
- W2036408906 hasConcept C2780739268 @default.
- W2036408906 hasConcept C2781303535 @default.
- W2036408906 hasConcept C2908647359 @default.
- W2036408906 hasConcept C2989005 @default.
- W2036408906 hasConcept C71924100 @default.
- W2036408906 hasConcept C99454951 @default.
- W2036408906 hasConceptScore W2036408906C126322002 @default.
- W2036408906 hasConceptScore W2036408906C136948725 @default.
- W2036408906 hasConceptScore W2036408906C141071460 @default.
- W2036408906 hasConceptScore W2036408906C141341695 @default.
- W2036408906 hasConceptScore W2036408906C142724271 @default.
- W2036408906 hasConceptScore W2036408906C143998085 @default.
- W2036408906 hasConceptScore W2036408906C151956035 @default.
- W2036408906 hasConceptScore W2036408906C167135981 @default.
- W2036408906 hasConceptScore W2036408906C2776694085 @default.
- W2036408906 hasConceptScore W2036408906C2778256501 @default.
- W2036408906 hasConceptScore W2036408906C2778629024 @default.
- W2036408906 hasConceptScore W2036408906C2780739268 @default.
- W2036408906 hasConceptScore W2036408906C2781303535 @default.
- W2036408906 hasConceptScore W2036408906C2908647359 @default.